Home › Therapeutic areas › Metabolic › Cushing's Syndrome

Cushing's Syndrome (2 companies)

Companies with an active program in Cushing's Syndrome.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CRNX Crinetics Pharmaceuticals MetabolicOncology Rare 1 Approved — 6
XERS Xeris Biopharma MetabolicNeurology Rare 1 Approved $2.78B 4